1Deng C,Goluszko E,Tuzun E,et al. Resistance to experimental autoimmune myasthenia gravis in IL-6-deficient mice is associated with reduced germinal center formation and C3 production[J]. J Immunol,2002,15:1077.
2Mocchegiani E,Giacconi R,Muzzioli M,et al. Different age-related effects of thymectomy in myasthenia gravis: role of thymoma,zinc,tymulin,IL-2 and IL-6[J].Mech Ageing Dev,2000,117:79.
3Birmanns B,Brenner T,Abramsky O,et al. Seronegative myasthenia gravis: clinical features,response to therapy and synthsis of acetylcholine receptor antibodies in vitro[J]. J Neurol Sci,1991,102:184.
4Huang WX,Huang P,Fredrikson S,et al. Decreased mRNA expression of TNF-alpha and IL-10 in non-stimulated peripheral blood mononuclear cell in myasthenia gravis[J]. Eur J Neurol,2000,7:195.
5Matusevicuis D,Navikas V,Palasik W,et al .Tumor necrosis factor-α lymphotoxin,interleukin(IL)-6,IL-10,IL-12 and perforin mRNA expression in mononuclear cells in respones to acetylcholine receptor is augmented in myasthenia gravis[J]. J Neuroimmunol,1996,71:191.
6Cohen-Kaminsky S,Devergne O,Delattre RM,et al. Interleukin-6 overproduction by cultured thymic epithelial cells from patients with myasthenia gravis is potentially involved in thymic hyperplasia[J].Eur Cytokine Netw,1993,4:121.
7Li H,Shi FD,Bai X,et al. Cytokine and chemokine mRNA expressing cells in muscle tissues of experimental autoimmune myasthenia gravis[J]. J Neurol Sci,1998,161:40
